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Background: We profiled the expression of circulating microRNAs (miRNAs) in mice using Illumina small RNA deep
sequencing in order to identify the miRNAs that may potentially be used as biomarkers to distinguish between
gram-negative and gram-positive bacterial infections.
Results: Recombinant-specific gram-negative pathogen Escherichia coli (Xen14) and gram-positive pathogen
Staphylococcus aureus (Xen29) were used to induce bacterial infection in mice at a concentration of 1 × 108
bacteria/100 μL of phosphate buffered saline (PBS). Small RNA libraries generated from the serum of mice after
exposure to PBS, Xen14, Xen29, and Xen14 + Xen29 via the routes of subcutaneous injection (I), cut wound (C), or
under grafted skin (S) were analyzed using an Illumina HiSeq2000 Sequencer. Following exposure to gram-negative
bacteria alone, no differentially expressed miRNA was found in the injection, cut, or skin graft models. Exposure to
mixed bacteria induced a similar expression pattern of the circulating miRNAs to that induced by gram-positive
bacterial infection. Upon gram-positive bacterial infection, 9 miRNAs (mir-193b-3p, mir-133a-1-3p, mir-133a-2-3p,
mir-133a-1-5p, mir-133b-3p, mir-434-3p, mir-127-3p, mir-676-3p, mir-215-5p) showed upregulation greater than
4-fold with a p-value < 0.01. Among them, mir-193b-3p, mir-133a-1-3p, and mir-133a-2-3p presented the most
common miRNA targets expressed in the mice exposed to gram-positive bacterial infection.
Conclusions: This study identified mir-193b-3p, mir-133a-1-3p, and mir-133a-2-3p as potential circulating miRNAs
for gram-positive bacterial infections.
Keywords: microRNAs (miRNAs), Circulating microRNAs, Gram-positive bacteria, Gram-negative bacteria, Small RNA
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MicroRNAs (miRNAs) are small regulatory RNA molecules
that are approximately 22 nucleotides long, modulate the
activity of specific mRNA targets, and play important roles
in a wide range of physiologic and pathologic processes [1].
Differential expression of miRNAs may help distinguish
between disease states [2-4]. miRNAs are themselves active
moieties and should therefore reflect physiological alter-
ations directly, which makes them ideal biomarkers for
distinguishing between diseased and healthy subjects [5].* Correspondence: m93chinghua@gmail.com
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unless otherwise stated.Moreover, circulating miRNAs in the blood are remark-
ably stable [6] and biochemical analyses indicate that
miRNAs are resistant to ribonuclease (RNase) activity, ex-
treme pH and temperature, extended storage, and large
numbers of freeze-thaw cycles [7,8]. Circulating miRNAs,
which can be easily detected by non-invasive methods,
have proven to be potentially valuable biomarkers for a
variety of diseases [9,10].
Early diagnosis of potential bacterial infection has be-
come the key approach to dealing with the infection illness
and to timely correction of the associated complications.
Microbiological culture is the gold standard in distinguish-
ing sepsis from other non-infectious diseases, but this tech-
nique is always time-consuming and can delay treatment.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with sepsis [11,12] and various infection diseases, such as
viral exposure [13,14], tuberculosis [15], and parasites
[16,17]. A distinct circulating miRNA expression was also
found in mice exposed to lipopolysaccharide (LPS) origin-
ating in the wall of gram-negative bacteria, as well as to
lipoteichoic acid (LTA), a major component of gram-
positive bacterial walls [18,19]. In addition, increasing evi-
dence has suggested that circulating miRNAs also have
important biologic functions [20]. Recently, the Illumina
deep sequencing platform has been used for efficient
miRNA discovery, and it is widely used to generate small
RNA profiles in various organisms. In this study, we pro-
filed the expression of the circulating miRNAs in a mouse
model of gram-negative and/or gram-positive bacterial in-
fection using Illumina small RNA deep sequencing.
Methods
Experimental design
Male C57BL/6 mice (age, 10–12 weeks; weight, 30–35 g)
were purchased from BioLasco (Yi-Lan, Taiwan). The
mice were anesthetized by intraperitoneal injection of an
anesthetic cocktail consisting of 0.1 mg/g ketamine and
0.01 mg/g xylazine. The anesthetized mice were re-
strained in a supine position on a heated pad to main-
tain body temperature at 37°C. Recombinant-specific
gram-negative pathogen Escherichia coli (Xen14) and
gram-positive pathogen Staphylococcus aureus (Xen29)
purchased from Caliper (Caliper, USA) were used to in-
duce bacterial infection in the mice at a concentration of
1 × 108 bacteria/100 μL of phosphate buffered saline
(PBS). To create mixed gram-negative and gram-positive
bacterial infection, 1 × 108 Xen14 bacteria and 1 × 108
Xen29 bacteria/100 μL of PBS were used for wound con-
tamination. Three animal models were used to create
bacterial infection routes: subcutaneous injection (here-
after referred to as (I)), cut wound (hereafter referred to
as (C)), and skin grafting (hereafter referred to as (S)). In
the (I) model, E. coli and/or S. aureus suspensions were
injected subcutaneously into the backs of the mice using
an Fr. 25 needle. In the (C) model, a 1 cm incision
wound was created in the midline of the back, smeared
with E. coli and/or S. aureus suspension, and the wound
was closed directly with a 4–0 nylon suture. In the (S)
model, a 1 × 1 cm rectangular full- thickness skin graft
was lifted from the backs of the mice, E. coli and/or
S. aureus suspensions were spread over the wound bed,
and the skin graft was reattached and closed with a 4–0
nylon suture. An additional group of animals in each of
these three models was inoculated with PBS to serve as
a negative control. The mice had ad libitum access to
food and water both before and after the surgery or ad-
ministration of bacterial infection. The mice were killed
24 h after the administration of bacterial infection, andthe whole blood was drawn and collected in RNAprotect
Animal Blood Tubes (cat.No. 76544, Qiagen, USA) with-
out anticoagulant. After the whole blood samples were in-
cubated at room temperature for 15 min, they were
centrifuged at 3000 × g for 10 min, white blood cells were
slowly removed from the corresponding layers, and the
serum was extracted and stored at −80°C before process-
ing for RNA analyses. All the housing conditions and the
surgical procedures, analgesia, and assessments were in
accordance with national and institutional guidelines, and
an Association for Assessment and Accreditation of La-
boratory Animal Care (AAALAC)-accredited SPF facility
was used. The animal protocols were approved by the In-
stitutional Animal Care and Use Committee (IACUC) of
Kaohsiung Chang Gung Memorial Hospital.
RNA isolation
Total RNA was extracted from the harvested serum
using a mirVana miRNA Isolation Kit (Ambion, USA).
The purified RNA yield was determined by the absorb-
ance at 260 nm with an SSP-3000 NanoDrop spectro-
photometer (Infinigen Biotech, USA), and RNA quality
was evaluated with a BioAnalyzer 2100 system (Agilent
Technologies, USA).
Small RNA library preparation
RNA smaller than 200 base pairs (bp) was enriched with
the mirVana miRNA isolation kit (Ambion). The small
RNA samples were sent to GeneTech Biotech Co., Ltd
(GeneTech, Taiwan) for small RNA cloning. The popula-
tion of miRNAs with a length of 15–30 nucleotides (nt)
was passively eluted from polyacrylamide gels. The RNA
was then precipitated with ethanol and dissolved in water.
Small RNAs had linkers ligated to them and bar-coded
cDNAs were prepared using a TruSeq Small RNA Sample
Prep Kit (Illumina, USA) following the manufacturer’s in-
structions. Briefly, 1 μg of small RNA was ligated with
adapters at 3′ and 5′ ends. Adapter-ligated RNA was
reverse-transcribed with SuperScript II Reverse Transcript-
ase (Invitrogen, USA), then PCR-amplified (15 cycles).
Samples were barcoded using 15 variants of the reverse
primer provided with the kit. The indexing barcode of this
kit after adapter ligation could significantly reduce sample
bias over previous indexing/barcoding approaches where a
barcode was ligated directly to the miRNA [21]. Individual
libraries were analyzed on a BioAnalyzer (Agilent) for the
presence of linked cDNA at the appropriate size (135–
165 bp) and 11 bar-coded libraries were pooled into 1 sam-
ple by mixing 2.0 ng of the 135–165 bp peak from each
sample, as determined by the BioAnalyzer.
Illumina small RNA deep sequencing
Sequencing of the pooled libraries was performed in 1 lane
of the Illumina HiSeq2000 Sequencer. Fifty bp single-end
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trimming of linker sequences, those reads of at least 15 nt
in length that had less than three terminal mismatches
in the sequence were sorted and counted for the following
analysis. The clean reads were aligned against the refer-
ence genome indices for mouse (M. musculus, UCSC
mm9) provided by the Bowtie site (http://bowtie-bio.
sourceforge.net/index.shtml) using BOWTIE software ac-
cording to the following criteria: a 5′ and 3′ linker match
of at least 15 nt and an appropriate length (15–29 nt).
The pre-miRNAs and mature miRNAs in the miRBase
v.20.0 were searched with BLAST to identifyMus musculus
miRNAs. To evaluate the quality of deep sequencing ex-
periments, five miRNAs detected by small RNA deep
sequencing were randomly selected and quantified by
qPCR using the Applied Biosystems 7500 Real-Time PCR
System (Life Technologies, USA) to confirm the up-
regulation of miRNA expression in Xen29 (I) group vs.
Xen29 (C) group. Twenty-five femto-molar of single
stranded cel-miR-39 synthesized by Invitrogen (Invitro-
gen) was spiked into 400 μL of serum as an internal con-
trol for the expression of each miRNA.
Results
Deep sequence analysis of small RNAs
To profile the circulating miRNAs expressed during
gram-negative and gram-positive bacterial infection, 12
small RNA libraries were generated from the serum of
mice after exposure to PBS, Xen14, Xen29, and Xen14 +
Xen29 via the routes of subcutaneous injection (I), cut
wound (C), or under grafted skin (S). These 12 small RNA
libraries were indicated as Contrl (I), Xen14 (I), Xen29 (I),
Xen14 + Xen29 (I), Contrl (C), Xen14 (C), Xen29 (C),
Xen14 + Xen29 (C), Contrl (S), Xen14 (S), Xen29 (S), and
Xen14 + Xen29 (S). The number and proportions of the
categories of small RNAs found are given in the Additional
file 1. In total, around 5424663 to 5999008 high-quality
raw reads were obtained from the serum libraries. After fil-
tering the low-quality sequences, empty adaptors and
single-read sequences, 92.58% to 97.85% clean reads of
15–29 nt were selected for further analysis (Additional
file 1: Table S1). The selected reads from these serum
libraries mapped well to the mice genome, amounting
to 74.19% and 79.32% of the total reads. The rest of
the sequences were found to be other types of RNA,
including noncoding RNA, rRNA, scRNA, snRNA, snoRNA,
srpRNA, and tRNA. The size distribution of small RNAs
(sRNAs) was similar in the 2 libraries, and the majority of
them were from 21 to 23 nt (Figure 1). The most abun-
dant size class was 22 nt, which accounted for ~40% of
the total reads in these libraries, followed by 23 nt for ~35%
(Additional file 1: Table S2). This result is typical of Dicer-
processed small RNA products and was consistent with the
known ~22 nt for miRNAs.Identification of known miRNAs
The Illumina small RNA deep sequencing approach al-
lows us to determine the relative abundance of various
miRNA families by calculating the sequencing frequency.
To investigate the expression of known miRNAs during
bacterial infection, identified small RNA sequences were
compared with known mature miRNAs in miRBase
v.20.0. The measured 814 mature miRNAs from these
12 libraries are listed (Additional file 1: Table S3).
Among them, there were 52 mature miRNAs with se-
quence reads ≥ 400 (Additional file 1: Table S4) and 10
mature miRNAs (mir-10b-5p, mir-133a-1-3p, mir-133a-
2-3p, mir-191-5p, mir-22-3p, mir-25-3p, mir-3107-5p,
mir-486-5p, mir-92a-1-3p, mir-92a-2-3p) with sequence
reads ≧ 4000 in at least 1 of the 12 twelve libraries
(Additional file 1: Table S5). In these libraries, known
miRNAs had a broad range of expression level; some
(such as mir-486-5p and mir-3107-5p) were found to
have hundreds of thousands of sequence reads, while
many others had less than 20, indicating that expression var-
ies significantly among different miRNA families. With more
than 6000 reads, 3 miRNAs (mir-486-5p, mir-3107-5p,
and mir-92a-3p) were dominantly expressed in all these
12 libraries (Additional file 1: Table S6). In addition to
mir-486-5p and mir-3107-5p, which have more than
200000 sequence reads in all 12 libraries, mir-92a-3p
was the third most abundant miRNA with sequence
reads ranging from 6659 to 16734 (Additional file 1:
Table S6). Small RNA deep sequencing and qPCR results
of five selected miRNAs (mir-133a-1-3p, mir-127-3p,
mir-25-3p, mir-191-5p, and mir-215-5p) were generally
in agreement, with a Pearson correlation value of 0.921
(Additional file 2).
Differentially-expressed miRNAs after bacterial infection
According to the changes in relative miRNA abundance
between the serum libraries from the mice receiving bac-
terial infection (Xen14, Xen29, and Xen14 + Xen29) and
PBS injection after 24 h, the differentially-expressed
miRNAs with sequence reads more than 400 in at least
1 of the libraries were selected for further comparison. It
was revealed that a total of 9 miRNAs (mir-193b-3p, mir-
133a-1-3p, mir-133a-2-3p, mir-133a-1-5p, mir-133b-3p,
mir-434-3p, mir-127-3p, mir-676-3p, mir-215-5p) showed
differences greater than 4-fold with p-value < 0.01 between
the 2 libraries (Table 1). Following exposure to gram-
negative bacteria alone, no differentially-expressed miR-
NAs were found in the injection, cut, or skin graft
models. Following exposure to gram-positive bacteria
in the injection and skin graft models, 7 upregulated
miRNAs (mir-193b-3p, mir-133a-1-3p, mir-133a-2-3p,
mir-133b-3p, mir-434-3p, mir-127-3p, mir-676-3p) and
1 downregulated miRNA (mir-215-5p) were found. In
addition, following exposure to gram-positive bacteria
Figure 1 Length distribution and abundance of small RNA sequences by Illumina small RNA deep sequencing in 12 libraries. Xen14:
recombinant-specific gram-negative pathogen Escherichia coli; Xen29: recombinant-specific gram-positive pathogen Staphylococcus aureus. Three
animal models were used to create bacterial infection routes: subcutaneous injection (I), cut wound (C), and skin graft (S), with 1 × 108 Xen14
and/or Xen29 bacteria in 100 μL of phosphate buffered saline (PBS).
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133a-2-3p) were upregulated and 1 miRNA (mir-215-
5p) was downregulated. Exposure to mixed bacteria
induced a similar expression pattern of the circulating
miRNAs to that induced by gram-positive bacterial
infection, but not to that induced by gram-negative bac-
terial infection. Unsupervised hierarchical cluster ana-
lysis (Figure 2) of all significant differentially-expressed
miRNAs also revealed the mixed gram-negative and
gram-positive bacteria induced a similar expression pat-
tern of the circulating miRNAs to that induced by
gram-positive bacterial infection, and gram-negative
bacteria induced a similar expression pattern of the cir-
culating miRNAs to that induced by the PBS in the con-
trol. Among these miRNAs, mir-193b-3p had the
highest fold-change of 61.5-fold and 40.4-fold in the in-
jection and skin graft models of gram-positive bacterial
infection, respectively, and of 13.9-fold and 13.0-fold in
the injection and skin graft models of mixed bacterial
infection, followed by mir-133a-1-3p and mir-133a-2-3p
in the gram-positive or mixed bacterial infection. There-
fore, we focused on these 3 differentially-expressed miR-
NAs (mir-193b-3p, mir-133a-1-3p, mir-133a-2-3p), and
their expression with sequence reads is illustrated in
Figure 3. Obviously, the expression of mir-133a-1-3p and
mir-133a-2-3p is similar in the 12 libraries. In addition,the high expression of mir-133a-1-3p and mir-133a-2-3p
upon gram-positive bacterial infection is reduced, al-
though still significant, in those mice with mixed bacterial
infection.
Discussion
The analysis of the serum libraries from the mice receiving
bacterial infection (Xen14, Xen29, and Xen14 + Xen29)
against those with PBS injection by small RNA deep se-
quencing after 24 h identified differentially-expressed miR-
NAs. Following exposure to gram-negative bacteria alone,
no differentially-expressed miRNAs were found in the in-
jection, cut, or skin graft models. This unexpected result
from gram-negative bacterial infection may be partly at-
tributed to characteristics of the selected skin infection
models (subcutaneous injection, cut, and skin graft), which
were generally responsive to inoculation by the gram-
positive bacteria, but not the gram-negative bacteria. In-
vestigation of the up-regulated circulating miRNAs with
different kinds of animal model which facilitate a gram-
negative bacteria inoculation, such as peritoneal injection,
enterocolitis, or induced pneumonia may be useful to clar-
ify the difference. In addition, the results seemed to con-
trast to our previous report that LPS injection induced
up-regulation of the miRNAs (let-7d, miR-15b, miR-16,
miR-25, miR-92a, miR-103, miR-107 and miR-451) of the
Figure 2 Unsupervised hierarchical clustering of the expression of miRNAs. Hierarchical clustering of miRNA differentially expressed in the
sera of the mice receiving Xen14, Xen29, Xen14 + Xen29, or PBS (as control) inoculation via subcutaneous injection (I), cut wound (C), or skin
graft (S).
Table 1 Differentially expressed miRNAs with sequence read > 400 and regulated greater than 4-fold in the sera of
C57BL/6 mice receiving bacterial infection for 24 h
Xen14: (I) Injection subcutaneously (C) Cut (G) Grafting of skin
miR-name Fold-change p miR-name Fold-change p miR-name Fold-change p
None None None
Xen29: (I) Injection subcutaneously (C) Cut (G) Grafting of skin
miR-name Fold-change p miR-name Fold-change p miR-name Fold-change p
mmu-mir-193b-3p 61.5 ** mmu-mir-133a-2-3p 4.7 ** mmu-mir-193b-3p 40.4 **
mmu-mir-133a-2-3p 21.0 ** mmu-mir-133a-1-3p 4.7 ** mmu-mir-133b-3p 7.0 **
mmu-mir-133a-1-3p 21.0 ** mmu-mir-215-5p 0.1 ** mmu-mir-133a-2-3p 6.6 **
mmu-mir-133b-3p 8.9 ** mmu-mir-133a-1-3p 6.6 **
mmu-mir-434-3p 6.2 ** mmu-mir-434-3p 5.7 **
mmu-mir-127-3p 5.5 ** mmu-mir-676-3p 5.2 **
mmu-mir-676-3p 5.0 ** mmu-mir-127-3p 5.1 **
mmu-mir-215-5p 0.1 ** mmu-mir-215-5p 0.1 **
Xen14 + Xen29: (I) Injection subcutaneously (C) Cut (G) Grafting of skin
miR-name Fold-change p miR-name Fold-change p miR-name Fold-change p
mmu-mir-193b-3p 13.9 ** mmu-mir-133a-2-3p 4.2 ** mmu-mir-193b-3p 13.0 **
mmu-mir-133a-2-3p 6.1 ** mmu-mir-133a-1-3p 4.2 ** mmu-mir-133a-1-5p 9.6 **
mmu-mir-133a-1-3p 6.1 ** mmu-mir-215-5p 0.2 ** mmu-mir-133a-2-3p 4.7 **
mmu-mir-215-5p 0.1 ** mmu-mir-133a-1-3p 4.7 **
mmu-mir-133b-3p 4.2 **
mmu-mir-434-3p 4.0 **
**, p-value < 0.01.
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Figure 3 Comparison of the sequence reads as the expression levels of 3 dominant circulation miRNAs (mir-133a-1-3p, mir-133a-2-3p,
and mir-193b-3p) in the sera of the mice receiving bacterial infection.
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In a single LPS injection, circulating miRNA induction oc-
curred after 2 h, persisted for at least 6 h, and declined
24 h [19]. Considering the amount of bacteria may vary
under the competition of bacterial growth and host
defense after inoculation, further experiment with in vivo
monitor at different observation time points may be help-
ful to give more information. In addition, for the same rea-
sons, it was expected and observed in this study that the
exposure to mixed bacteria induced a similar expression
pattern of the circulating miRNAs to that induced by
gram-positive bacterial infection. However, it is noted that
the number of upregulated miRNAs and their high level
of expression upon gram-positive bacterial infection was
remarkably decreased in those mice with mixed bacterial
infection, suggesting that the competition of different
types of bacteria has an impact on the expression of circu-
lation miRNA.
In this study, there were 8 upregulated miRNAs (mir-
193b-3p, mir-133a-1-3p, mir-133a-2-3p, mir-133a-1-5p,
mir-133b-3p, mir-434-3p, mir-127-3p, mir-676-3p) and 1
downregulated miRNA (mir-215-5p) present as potential
targets for differentiation between gram-negative and
gram-positive bacterial infection. The analysis of multiple
miRNAs in parallel to increase sensitivity and specificity by
using complex miRNA expression patterns might consti-
tute very useful and accessible diagnostic tools in a cluster
pattern [5,7]. However, the detection of the type of infected
bacteria should not be interfered from the animal model
approach, particularly since the inoculation methods such
as subcutaneous injection, cut, or skin grafting were not
expected to have a great impact on circulating miRNA
expression. Therefore, the 3 most common circulating
miRNAs (mir-193b-3p, mir-133a-1-3p, and mir-133a-2-3p)
expressed in the mice exposed to Staphylococcus aureus in
the absence or presence of Escherichia coli may be poten-
tial biomarkers for gram-positive bacterial infection. How-
ever, whether these 3 circulating miRNAs would expressed
in the mice exposed to other species of gram-positive bac-
teria require further validation.A functional role of miR-133a and miR-193b was re-
cently revealed in systemic inflammatory responses associ-
ated with infections, myocardial infarction, and cancer.
Significant alterations of miR-133a, miR-193b, miR-150,
and miR-155 were found in mice after cecal pole ligation
and puncture-induced sepsis [12]. Although miR-193b has
been considered a tumor suppressor gene, and modulates
proliferation, migration, and invasion of the cancer cells
[22-25], it has been reported to be associated with death
from sepsis in an analysis of 214 sepsis patients (117 survi-
vors and 97 non-survivors based on 28-day mortality) [26].
Furthermore, miR-133a is deemed a cardiac and skeletal
muscle-specific miRNA [27,28] and involved in muscle de-
velopment [29] and many myocardial diseases [29-32]. Sig-
nificantly elevated miR-133a levels were found in critically
ill patients at intensive care unit (ICU) admission, espe-
cially in patients with sepsis [12]. In addition, correlation
analyses revealed significant correlations of miR-133a with
disease severity, classical markers of inflammation and
bacterial infection, and organ failure [12]. Notably, genes
encoding miR-133, namely miR-133a-1, miR-133a-2, are
transcribed as bicistronic transcripts together with miR-1-1
and miR-1-2 [29]. The remarked increase in expression of
mir-133a-1-3p and mir-133a-2-3p upon gram-positive bac-
terial infection in the present study was not accompanied
by an increased expression of mir-1-1 or mir-1-2. Whether
the upregulation of these circulating miRNAs is attribut-
able to direct stimulation by gram-positive bacterial toxin
or by a parallel effect, such as hemodynamic change or an
associated illness, is unknown. Therefore, the origin and
mechanism of the increased expression of mir-133a-1-3p
and mir-133a-2-3p may require further investigation prior
to their application in a clinical setting.
Conclusion
In conclusion, this study profiled circulating miRNAs in
mice exposed to gram-negative and gram-positive bac-
teria using Illumina small RNA deep sequencing, and
identified the miRNAs that may potentially be used as
biomarkers of gram-positive bacterial infections.
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known miRNAs with sequence reads > 400 in at least one of the 12
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expression patterns of known miRNAs with sequence reads > 4000 in
at least one of the 12 libraries of sera of C57BL/6 mice receiving Xen14
or/and Xen29 bacteria infection by subcutaneous injection, cut, or skin
grafting. Table S6. The most top 15 expressed miRNAs with sequence
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Additional file 2: Correlation of the expression of five selected
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